Eveksia Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 129.35%
- Profit Growth 246.33%
- Ebitda 360.42%
- Net Worth 125.60%
- Total Assets 105.27%
About Eveksia Pharma
Eveksia Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2017 (Seven years and six months 21 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandan Singh, Raghubar Bharti, and Mukesh Bharti serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110DL2017PTC321810
- Company No.
321810
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Eveksia Pharma Private Limited offer?
Eveksia Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Protein Powder, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Digestive System Drugs & Medicines, Antacid Drugs, Multivitamin Tablets & Capsules, Weight Loss Supplement.
Who are the key members and board of directors at Eveksia Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Bharti  | Director | 07-Aug-2017 | Current |
| Chandan Singh | Director | 24-Feb-2020 | Current |
| Raghubar Bharti | Director | 07-Aug-2017 | Current |
Financial Performance of Eveksia Pharma.
Eveksia Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 129.35% increase. The company also saw a substantial improvement in profitability, with a 246.33% increase in profit. The company's net worth Soared by an impressive increase of 125.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eveksia Pharma?
In 2023, Eveksia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Manlive Pharma Private LimitedChandan Singh is a mutual person
- Unrogya Pharmacy Private Limited
Raghubar Bharti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eveksia Pharma?
Unlock and access historical data on people associated with Eveksia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eveksia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eveksia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.